HIFIBIO
HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. The company was founded in 2013 and is headquartered in Paris, Ille-de-France.
HIFIBIO
Industry:
Biopharma Biotechnology Pharmaceutical Therapeutics
Founded:
2013-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.hifibio.com
Total Employee:
101+
Status:
Active
Contact:
+33179350790
Total Funding:
179.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Apache Wordpress Plugins
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Current Advisors List
Board_member
2021-06-14
Current Employees Featured
Robert Nicol Co-Founder @ HiFiBiO
Co-Founder
2013-01-01
Jeff He Chief Operating Officer @ HiFiBiO
Chief Operating Officer
2017-01-01
Fred Dom Chief Financial Officer @ HiFiBiO
Chief Financial Officer
Nicola Beltraminelli Head of Drug Sciences and Vice President @ HiFiBiO
Head of Drug Sciences and Vice President
2019-06-01
Franciscc Adrian Head of Global Disease Biology and Vice President @ HiFiBiO
Head of Global Disease Biology and Vice President
2018-04-01
Annabelle Gerard Head of External Innovation and Senior Director @ HiFiBiO
Head of External Innovation and Senior Director
2019-06-01
Robert G. Petit Senior Medical & Scientific Advisor @ HiFiBiO
Senior Medical & Scientific Advisor
2020-04-01
Liang Schweizer Co-Founder, CEO & CSO @ HiFiBiO
Co-Founder, CEO & CSO
2017-08-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-10-15 | H-Immune Therapeutics | H-Immune Therapeutics acquired by HiFiBiO | N/A |
Investors List
Grand Mount Capital
Grand Mount Capital investment in Series D - HiFiBiO
IDG Capital
IDG Capital investment in Series D - HiFiBiO
Mirae Asset Capital
Mirae Asset Capital investment in Series D - HiFiBiO
Legend Star
Legend Star investment in Series D - HiFiBiO
Maison Capital
Maison Capital investment in Series D - HiFiBiO
Sequoia Capital China
Sequoia Capital China investment in Series D - HiFiBiO
Hengxu Capital
Hengxu Capital investment in Series D - HiFiBiO
Sherpa Venture Capital
Sherpa Venture Capital investment in Series D - HiFiBiO
B Capital Group
B Capital Group investment in Series D - HiFiBiO
Hong Kong Science and Technology Parks Corporation (HKSTP)
Hong Kong Science and Technology Parks Corporation (HKSTP) investment in Series D - HiFiBiO
Official Site Inspections
http://www.hifibio.com Semrush global rank: 5.53 M Semrush visits lastest month: 1.54 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "HiFiBiO"
HiFiBiO - Crunchbase Company Profile & Funding
HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and …See details»
Company Overview - HiFiBio Therapeutics
HiFiBiO Therapeutics is a clinical-stage biotech driving a pipeline of transformative immunotherapies. About. Company Overview; Leadership; Scientific Advisory Board; Board of Directors; Scientific Founders; Contact; …See details»
About - HiFiBio Therapeutics
HiFiBiO Therapeutics is a clinical-stage biotech driving a pipeline of transformative immunotherapies. About. Company Overview; Leadership; Scientific Advisory Board; Board of …See details»
HiFiBiO Therapeutics - LinkedIn
HiFiBiO Therapeutics is a clinical-stage global biotech pioneering a unique high-resolution translational solution (DIS®, Drug Intelligence Science) to enhance the probability of success for ...See details»
HiFiBiO - Org Chart, Teams, Culture & Jobs - The Org
HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates deep-rooted biological expertise …See details»
HiFiBiO - Contacts, Employees, Board Members, Advisors & Alumni
Organization. HiFiBiO . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 8. Number of Board …See details»
HiFiBiO Therapeutics 2025 Company Profile: Valuation, Funding ...
HiFiBiO Therapeutics was founded in 2013. Where is HiFiBiO Therapeutics headquartered? HiFiBiO Therapeutics is headquartered in Cambridge, MA. What is the size of HiFiBiO …See details»
HiFiBiO - Funding, Financials, Valuation & Investors - Crunchbase
HiFiBiO has acquired H-Immune Therapeutics on Oct 15, 2018. Unlock for free . Funding Rounds. Edit Funding Rounds Section. Number of Funding Rounds 5. ... How much funding has this …See details»
HiFiBiO Therapeutics - VentureRadar
Aug 8, 2018 HiFiBiO Therapeutics is a pioneer of novel antibody drug discovery and development by leveraging single-cell analytics to treat cancer, autoimmune and infectious …See details»
Hifibio - High Fidelity Biology Company Information - Funding ...
Hifibio - High Fidelity Biology is a single cell technologies for drug discovery founded in 2013 by Liang Schweizer, Jeff He and Robert Nicol. Seedtable Score 76 Startups. 4. Funding Rounds. …See details»
HiFiBio (HK) Limited - hkstp.org
HiFiBiO Therapeutics is a clinical stage biotech company advancing a robust pipeline targeting both the innate and adaptive immunity to treat cancer and autoimmune disease. Our …See details»
HiFiBiO's CEO and Executive Team - Team members and org chart
The HiFiBiO executive team has a wealth of experience in the biotech and pharmaceutical industry. The team members have worked at companies such as Novartis, Merrimack, Bristol …See details»
Join Us - HiFiBio Therapeutics
We adjust rapidly as our organization grows and are ready to take on new challenges. We empower decision making for individuals while aligning closely under our shared vision, …See details»
HiFiBio SAS - life-sciences-europe.com
HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates deep-rooted biological expertise …See details»
Hifibio SAS - Drug pipelines, Patents, Clinical trials - Synapse
HiFiBiO plans to begin a single ascending dose (SAD) Phase 1 clinical study in a healthy volunteer cohort, followed by a multiple ascending dose (MAD) study in patients with selected …See details»
HiFiBiO Therapeutics (Hangzhou) Co., Ltd. - synapse.zhihuiya.com
了解HiFiBiO Therapeutics (Hangzhou) Co., Ltd. (高诚生物医药（杭州）有限公司)公司的药物管线，治疗领域，技术平台，以及它的3项临床试验, 1篇新闻和1篇文献，疾病领域:肿瘤，内分泌 …See details»
News - HiFiBio Therapeutics
HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases All …See details»
Redefining the role of hypoxia-inducible factors (HIFs) in oxygen ...
Mar 16, 2025 Normoxia and hypoxia have become standard experimental conditions in the field since the seminal studies that led to the discovery of HIFs. Now, oxygen tensions within the …See details»
Scientific Founders - HiFiBio Therapeutics
HiFiBiO Therapeutics is a clinical-stage biotech driving a pipeline of transformative immunotherapies. About. Company Overview; Leadership; ... epigenetics—changes in gene …See details»
HiFiBiO | Antibody Drug Discovery | Immune Modulation | Job …
HiFiBio is actively recruiting top scientific talent. Learn more about our available positions. HiFiBiO Therapeutics has been named as one of Fierce Biotech’s Fierce 15 of 2023!See details»